Evaluation of Efficacy and Safety of Fixed Dose Lovastatin and NiacinER Combination in Asian Indian Dyslipidemic Patients: A Multicentric Study

@article{Sharma2006EvaluationOE,
  title={Evaluation of Efficacy and Safety of Fixed Dose Lovastatin and NiacinER Combination in Asian Indian Dyslipidemic Patients: A Multicentric Study},
  author={Manoj Sharma and Deepika Rohtagi Sharma and Vikram Singh and RB Panwar and H. S. Hira and Bishav Mohan and Naveen Kumar and S. Sharma and Rajeev Gupta},
  journal={Vascular Health and Risk Management},
  year={2006},
  volume={2},
  pages={87 - 93}
}
Asian Indian dyslipidemia is characterized by: borderline high low-density lipoprotein (LDL) cholesterol and apolipoprotein (apo) B; high triglycerides, low high-density lipoprotein (HDL) cholesterol and apoA1; and high lipoprotein(a) (lp[a]). We performed a controlled multicentric trial in India to evaluate the efficacy and safety of a fixed dose… CONTINUE READING